Ongoing clinical trials offer hope for people born with genetic mutation behind fibrodysplasia ossificans
Several teams of medical researchers are currently testing new therapies for slowing or stopping the excess or runaway bone growth associated with fibrodysplasia ossificans progressive (FOP)—a rare bone disease.